Vault-13

NEUBASE THERAPEUTICS INC

COM · CUSIP 64132K102

1 institutional holders -2 vs Q2 2023
46,97047.0k shares reported held*
$40.9kreported value*
0 new 0 added 0 reduced 2 sold out net sold ≈ $43.7k (-50.2k shares)

* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $0.87.

Trends to Q3 2023

Institutional holders

Managers reporting a position, each quarter

0204060Q3 22: 45Q4 22: 36Q1 23: 37Q2 23: 3Q3 23: 11Q3 22Q4 22Q1 23Q2 23Q3 23
Numbers
QuarterHolders
Q3 202245
Q4 202236
Q1 202337
Q2 20233
Q3 20231

Buyers vs sellers

Managers adding to or starting a position, vs cutting or selling out

Bought or addedCut or sold out
40040Q4 22: 9 bought or addedQ4 22: 22 cut or sold outQ4 22Q1 23: 9 bought or addedQ1 23: 10 cut or sold outQ1 23Q2 23: 1 bought or addedQ2 23: 37 cut or sold outQ2 23Q3 23: 0 bought or addedQ3 23: 2 cut or sold outQ3 23
Numbers
QuarterBought or addedCut or sold out
Q4 2022922
Q1 2023910
Q2 2023137
Q3 202302

Biggest buyers

None

Biggest sellers

Decheng Capital Management III (Cayman), LLC Sold out -50,000-50.0k
IFP Advisors, Inc Sold out -200-200

Holders, Q3 2023

#ManagerLocationShares Value% of their portfolioChangeShares change
1 Carnegie Mellon University 0.05% of their portfolio Pittsburgh, PA 46,97047.0k $40.9k $40.9k 0.05% Unchanged